Balancing efficacy and toxicity of a fibroblast activation protein dependent tetravalent CD40 agonist antibody for cancer therapy

被引：1
|
作者：
Chen, Simeng
Lin, Yuan
Zhou, Xiaoru
Sun, Xing
Yang, Changyong
Liao, Cheng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2366
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2366
引用
收藏
页数：2
相关论文
共 50 条
  • [1] AJ17 potentiates agonist CD40 antibody efficacy and attenuates agonist CD40 induced PD-L1 expression and associated toxicity in murine tumor models
    Gaur, Vidit
    Barnwal, Anjali
    Ateeq, Bushra
    Bhattacharyya, Jayanta
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy
    Laura A. Vitale
    Lawrence J. Thomas
    Li-Zhen He
    Thomas O’Neill
    Jenifer Widger
    Andrea Crocker
    Karuna Sundarapandiyan
    James R. Storey
    Eric M. Forsberg
    Jeffrey Weidlick
    April R. Baronas
    Lauren E. Gergel
    James M. Boyer
    Crystal Sisson
    Joel Goldstein
    Henry C. Marsh
    Tibor Keler
    Cancer Immunology, Immunotherapy, 2019, 68 : 233 - 245
  • [3] Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy
    Thomas, Lawrence
    Vitale, Laura
    O'Neill, Thomas
    Widger, Jenifer
    Crocker, Andrea
    He, Li-Zhen
    Weidlick, Jeffrey
    Sundarapandiyan, Karuna
    Storey, James
    Forsberg, Eric
    Pilsmaker, Catherine
    Gergel, Lauren
    Do, Elizabeth
    Goldstein, Joel
    Marsh, Henry
    Keler, Tibor
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [4] Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy
    Vitale, Laura A.
    Thomas, Lawrence J.
    He, Li-Zhen
    O'Neill, Thomas
    Widger, Jenifer
    Crocker, Andrea
    Sundarapandiyan, Karuna
    Storey, James R.
    Forsberg, Eric M.
    Weidlick, Jeffrey
    Baronas, April R.
    Gergel, Lauren E.
    Boyer, James M.
    Sisson, Crystal
    Goldstein, Joel
    Marsh, Henry C., Jr.
    Keler, Tibor
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 233 - 245
  • [5] Efficacy of CDX-1140, an agonist CD40 antibody, in preclinical tumor models
    Thomas, Lawrence J.
    He, Li-Zhen
    Testa, James
    Wasiuk, Anna
    Weidlick, Jeffrey
    Sisson, Crystal
    Vitale, Laura A.
    O'Neill, Thomas
    Forsberg, Eric
    Pilsmaker, Catherine D.
    Gergel, Lauren E.
    Do, Elizabeth Q.
    Boyer, James
    Baronas, April R.
    Rocheleau, Mallary
    Grealish, Michelle E.
    Borrelli, Kathleen M.
    Marsh, Henry C.
    Keler, Tibor
    CANCER RESEARCH, 2018, 78 (13)
  • [6] CD40 agonist targeted to Fibroblast activation protein a synergizes with radiotherapy in murine HPV-positive head and neck tumors
    Labiano, S.
    Roh, V.
    Godfroid, C.
    Hiou-Feige, A.
    Romero, J.
    Sum, E.
    Rapp, M.
    Boivin, G.
    Wyss, T.
    Simon, C.
    Bourhis, J.
    Umana, P.
    Trumpfheller, C.
    Tolstonog, G.
    Vozenin, M. C.
    Romero, P.
    SWISS MEDICAL WEEKLY, 2021, 151 : 13S - 13S
  • [7] CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors
    Labiano, Sara
    Roh, Vincent
    Godfroid, Celine
    Hiou-Feige, Agnes
    Romero, Jackeline
    Sum, Eva
    Rapp, Moritz
    Boivin, Gael
    Wyss, Tania
    Simon, Christian
    Bourhis, Jean
    Umana, Pablo
    Trumpfheller, Christine
    Tolstonog, Genrich, V
    Vozenin, Marie-Catherine
    Romero, Pedro
    CLINICAL CANCER RESEARCH, 2021, 27 (14) : 4054 - 4065
  • [8] Identification and characterization of a human CD40 agonist antibody with efficacy against human tumors in SCID mice
    Gladue, R. P.
    Bedian, V.
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
    Liu, Hsuan-Chen
    Davila Gonzalez, Daniel
    Viswanath, Dixita Ishani
    Vander Pol, Robin Shae
    Saunders, Shani Zakiya
    Di Trani, Nicola
    Xu, Yitian
    Zheng, Junjun
    Chen, Shu-Hsia
    Chua, Corrine Ying Xuan
    Grattoni, Alessandro
    ADVANCED SCIENCE, 2023, 10 (09)
  • [10] Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
    Sum, Eva
    Rapp, Moritz
    Froebel, Philipp
    Le Clech, Marine
    Durr, Harald
    Giusti, Anna Maria
    Perro, Mario
    Speziale, Dario
    Kunz, Leo
    Menietti, Elena
    Bruenker, Peter
    Hopfer, Ulrike
    Lechmann, Martin
    Sobieniecki, Andrzej
    Appelt, Birte
    Adelfio, Roberto
    Nicolini, Valeria
    Freimoser-Grundschober, Anne
    Jordaan, Whitney
    Labiano, Sara
    Weber, Felix
    Emrich, Thomas
    Christen, Francois
    Essig, Birgit
    Romero, Pedro
    Trumpfheller, Christine
    Umana, Pablo
    CLINICAL CANCER RESEARCH, 2021, 27 (14) : 4036 - 4053
12345